All HCCI Reports
HCCI’s original reports powered by #HCCIdata

CNBC: Walmart unveils low-price insulin as more patients with diabetes struggle to pay for drug

HCCI's research on the price of insulin was featured in CNBC. 

From the article: "As the number of people with diabetes climbs, the cost of the 100-year-old drug has soared rather than fallen and drawn scrutiny from lawmakers. The annual cost of insulin for people with Type 1 diabetes in the U.S. nearly doubled from $2,900 in 2012 to $5,700 in 2016, according to the most recent data available from the Health Care Cost Institute."

...

Walmart unveils low-price analog insulin amid rising diabetes drug costs

Walmart said Tuesday it will offer a less expensive version of insulin that could better fit into the budgets of millions of Americans who don't have health insurance or struggle to pay for the lifesaving diabetes drug.
×
Stay Informed

When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.